Clinical Trials in Atlanta

Showing 6981-7000 of 19,805 trials

Coaching for Advanced Practice Providers

NCT05938556

This study aims to determine if online coaching is feasible in advanced practice providers (APP) and can impact burnout. The study will recruit APPs from Children's Healthcare of Atlanta (CHOA), Emory, Colorado University (CU), and their affiliate hospitals through online consent sent via email. Interventions will include online video coaching, written coaching, and self-coaching through self-study material.

Burnout, Professional

Emory University319 participantsStarted Jul 2023

Denver, Colorado, United States • Atlanta, Georgia, United States • Atlanta, Georgia, United States +1 more locations

COMPLETEDPhase 1< 1 mile

Everolimus With Multiagent Re-Induction Chemotherapy in Pediatric Patients With ALL

NCT01523977

Laboratory and other studies suggest that, the study drug, Everolimus (RAD001), may prevent tumor cell growth and also may increase the efficacy of other chemotherapy drugs. Everolimus is approved for use in the United States for certain types of cancer, such as kidney cancer. It has been extensively studied in people with various types of cancer as a single agent (a drug that is used alone to treat the cancer) or in combination with a number of other drugs. Studies in adults with cancer have also evaluated Everolimus in combination with other anti-tumor drugs. Information from lab studies and some other clinical trials suggests that Everolimus may kill leukemia cells on its own, and also make it more likely that steroids (such as prednisone) are able to kill leukemia cells. In this research study, we are looking to learn more about how Everolimus works in combination with other drugs which are commonly used to treat relapsed acute lymphoblastic leukemia (prednisone, vincristine, PEG-asparaginase, and doxorubicin). The main goal of the study is to evaluate the side effects of this treatment combination in order to determine a safe dose of Everolimus which can be given with these other 4 drugs.

Acute Lymphoblastic Leukemia

Dana-Farber Cancer Institute22 participantsStarted Nov 2011

San Francisco, California, United States • Aurora, Colorado, United States • Atlanta, Georgia, United States +5 more locations

Coaching for Advanced Practice Providers

Everolimus With Multiagent Re-Induction Chemotherapy in Pediatric Patients With ALL

Find Trials by Condition in Atlanta

Laparotomy vs. Drainage for Infants With Necrotizing Enterocolitis

Chiauranib for Advanced Solid Malignant Tumors and Relapsed/Refractory SCLC.

Pepinemab in Treating Younger Patients With Recurrent, Relapsed, or Refractory Solid Tumors

Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma

Study to Evaluate the Efficacy Safety and Tolerability of Ultevursen in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene (Sirius)

Belimumab Assessment of Safety in SLE

Oral Nutritional Supplementation in Children at Risk of Undernutrition

Open-label, Uncontrolled Phase II Trial of Intravenous PI3K Inhibitor BAY80-6946 in Patients With Relapsed, Indolent or Aggressive Non-Hodgkin's Lymphomas

Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia

Design Validation of Toric Contact Lenses in Senofilcon A With a Blue-Blocking Chromophore

A Study of the Safety, Efficacy, and Biomarker Response of BMS-986165 in Participants With Moderate to Severe Ulcerative Colitis

Chronic Pain Master Protocol (CPMP): A Study of LY3526318 in Participants With Osteoarthritis

A Study of the Safety and Tolerability of LPCN 1144 in Subjects Who Completed the LPCN 1144-18-002 Trial

A Study to Learn How the Body Processes the Study Medicine Called PF-07923568 in People With Loss of Kidney Function

C-myc Biomarker Study for Diabetic Foot Ulcers

Safety and Efficacy of ARQ-252 Cream 0.3% in Subjects With Non-Segmental Facial Vitiligo

Safety of Repeat Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Adult Subjects With Retinitis Pigmentosa

AI-enabled Endoscopic Prediction of Post-operative Recurrence in Crohn's Disease